• About
    • The Forum Team
    • Public Meetings
      • Current Meetings
      • Past Meetings
    • Policy Series
      • Current Projects
        • Hepatitis B Elimination
      • Completed Projects
        • 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care
        • 2012 National Summit on HIV and Viral Hepatitis
    • Employment Opportunities
    • Internships and Fellowships
    • Achievements
    • Join our Email Service
    • Awards
      • Global Health Catalyst
      • C. Everett Koop Public Health Leadership Award
      • John G. Bartlett Award for Catalyzing Clinical Research to Improve Global Health
    • News
      • Upcoming Events
      • Forum Press Releases
      • Announcements
      • Interviews
      • Archive
    • Completed Projects
      • HCV Forum
        • HCV Forum Overview
        • Sponsors
        • Working Groups
        • Meetings
        • HCV Drug Resistance Slide Set
        • HCV Drug Resistance Mutations
        • Additional Projects of the HCV Forum
  • HBV & HDV
    • HBV & HDV Forum Overview
    • Steering Committee
    • Meetings
    • Publications
    • Sponsors
  • HIV
    • HIV Prevention
      • Overview
      • Steering Committee
      • Meetings
    • HIV Treatment and Cure
      • Overview
      • Planning Groups and Scientific Advisory Committees
      • Meetings
    • Publications
    • Archive
    • Sponsors
  • Liver
    • Liver Forum Overview
    • Steering Committee
    • ACLF
    • Pediatric Cholestatic Disease Program
    • Meetings
      • Meetings
      • Related Meetings
    • Publications
    • Sponsors
  • PSC
    • PSC Forum Overview
    • Steering Committee
    • Meetings
    • Databases/Registries
    • Sponsors
  • Rare
    • Rare Diseases Forum Overview
    • Meetings
    • Sponsors
  • TAVI
    • TAVI Forum Overview
    • Steering Committee
    • Meetings
    • Publications
    • Sponsors
  • Ocular
    • Ocular Diseases Forum Overview
    • Steering Committee
    • Meetings
    • Sponsors
  • Data & Analysis Center
    • Data Center Overview
    • Projects
      • MASH Placebo Arm Project
  • Education
    • PBHLTH 236 - U.S. Food and Drug Administration, Drug Development, Public Health And Health Policy
    • PBHLTH 266E - DIAGNOSTICS IN INFECTIOUS DISEASES: DEVELOPMENT, REGULATORY AND IMPLEMENTATION CHALLENGES
  • Publications
    • Recent Publications
    • Annals of the Forum
The Forum For Collaborative Research Logo
Newsletter Signup

HIV Archive

STI-HIV Incidence Correlation in MSM

E-mail Print

STI-HIV Incidence Correlation in MSM Working Group

  • Focuses on investigating whether an HIV Incidence Index can be constructed by correlating HIV-STI incidence rates in MSM cohorts.
    • Abstract submitted to the HIV Research for Prevention Conference (HIVR4P//Virtual) 2021: https://www.hivr4p.org
 

The HIV Cure Project

E-mail Print

The HIV Cure Project

This project was established in 2013 with special NIH funding to address regulatory hurdles in HIV cure interventions in the following areas:

  • Preclinical animal models, biomarkers, endpoints and assays, as well as the definition of cure in a clinical trial setting
  • The clinical science and management of HIV cure trials: cell activation/reversal of latency, immune-based, and gene therapy
  • Ethics and fairness in trial recruitment, patient education, and informed consent

Click here for the HIV Cure Project Leadership list

Click here for more information about the HIV Cure Project

 

PrEP Regulatory and Research Issues Planning Meeting

PrEP Regulatory and Research Issues Planning Meeting
June 23, 2016
Arlington, VA

Read more »
 

AVAC/CONRAD/FORUM Workshop on Alternative Trial Designs for Microbicides

On June 23, 2014, CONRAD, AVAC and the Forum for Collaborative HIV Research convened a workshop on alternative trial designs for microbicides which generated lively discussion among more than 60 participants. A number of possible designs were presented, as described in the attached proceedings.
Read more »
 

Future of PrEP and Microbicide Research: Trial Design and Regulatory Issues

JAN-07-13 With the FDA approval and availability of Truvada for PrEP, clinical trial design and regulatory issues facing PrEP and microbicide trials must be considered to facilitate research and development of new prevention modalities.

Read more »
 

More Articles...

  • Safer Conception and Reproductive Options for HIV-Infected Individuals and Serodiscordant Couples
  • Safety Issues in Pre-exposure Prophylaxis
  • Controlling the HIV Epidemic - The Promise of ARV-Based Prevention
  • Pre-Exposure Prophylaxis (PrEP) Trials Working Group
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »
Page 1 of 3
 
  • HIV Prevention
    • Overview
    • Steering Committee
    • Meetings
  • HIV Treatment and Cure
    • Overview
    • Planning Groups and Scientific Advisory Committees
    • Meetings
  • Publications
  • Archive
  • Sponsors

News

  • Improved Survival of Patients with Alagille Syndrome and Native Liver into Adolescence: An Interview with Dominika Wojdyla about EASL 2026
    August 27, 2026
  • Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working group
    July 10, 2026
  • Largest Multicenter Study to Date on Refractory HSV in HCT Recipients: Forum Publication in Open Forum Infectious Diseases
    July 08, 2026

Events

  • Advances in HIV post-exposure prophylaxis (PEP): Regulatory challenges and clinical trial designs
    July 08, 2026
  • HBV Forum 16
    May 26, 2026
    Read more »
  • TAVI Forum 14
    April 30, 2026
    Read more »
 
The Forum for Collaborative Research
1608 Rhode Island Avenue NW, Suite 212 
Washington, DC 20036

Email: [email protected]

forum logo 2024 1

ucb sph logo 2024 vertical no endorser transparent

 

Copyright © 2026 The Forum for Collaborative Research. All Rights Reserved.

Powered by Non-Profit Soapbox